Symbol="CARA"
AssetType="Common Stock"
Name="Cara Therapeutic"
Description="Cara Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on itching and pain by selectively targeting kappa opioid receptors in the United States. The company is headquartered in Stamford, Connecticut."
CIK="1346830"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="4 STAMFORD PLAZA, 107 ELM STREET 9TH FLOOR, STAMFORD, CT, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="151958000"
EBITDA="-114902000"
PERatio="None"
PEGRatio="0"
BookValue="2.015"
DividendPerShare="0"
DividendYield="0"
EPS="-2.09"
RevenuePerShareTTM="0.505"
ProfitMargin="0"
OperatingMarginTTM="-4.237"
ReturnOnAssetsTTM="-0.399"
ReturnOnEquityTTM="-0.713"
RevenueTTM="27172000"
GrossProfitTTM="-56141000"
DilutedEPSTTM="-2.09"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.699"
AnalystTargetPrice="16.86"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="15.22"
PriceToBookRatio="3.399"
EVToRevenue="12.05"
EVToEBITDA="-5.31"
Beta="0.854"
num_52WeekHigh="12.81"
num_52WeekLow="2.56"
num_50DayMovingAverage="2.997"
num_200DayMovingAverage="6.65"
SharesOutstanding="54078000"
DividendDate="None"
ExDividendDate="None"
symbol="CARA"
open="2.73"
high="2.78"
low="2.56"
price="2.57"
volume="621261.00"
latest_trading_day="2023-08-31"
previous_close="2.73"
change="-0.16"
change_percent="-5.8608%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="100"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Trending High"
value_analysis="Bullish Trend"
Aroon_change="FALSE"
Aroon_momentum="0"
Volume_recent_avg="1080065"
Change_recent_avg="-0.02"
Delta_recent_avg="0.21"
Variance_recent_avg="0.11"
Change_ratio_recent_avg="-0.74"
RSI_change="FALSE"
ADX_change="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="0"
Aroon_momentum_negative="100"
image_negative_thumbnail_id_1="1127"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0160.jpeg"
image_negative_thumbnail_id_2="136"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0040.jpeg"
image_neutral_thumbnail_id_1="533"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0066.jpeg"
image_neutral_thumbnail_id_2="558"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0041.jpeg"
image_positive_thumbnail_id_1="618"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0090.jpeg"
image_positive_thumbnail_id_2="1011"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0173.jpeg"
image_professor_thumbnail_id_1="1173"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0007.jpeg"
image_professor_thumbnail_id_2="1190"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0024.jpeg"
